Antiviral mechanisms and preclinical evaluation of amantadine analogs that continue to inhibit influenza A viruses with M2S31N-based drug resistance
To better manage seasonal and pandemic influenza infections, new drugs are needed with enhanced activity against amantadine- and rimantadine-resistant…
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
April 2025
|
| In: |
Antiviral research
Year: 2025, Volume: 236, Pages: 1-11 |
| ISSN: | 1872-9096 |
| DOI: | 10.1016/j.antiviral.2025.106104 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.antiviral.2025.106104 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0166354225000300 |
| Author Notes: | Ian Tietjen, Daniel C. Kwan, Annett Petrich, Roland Zell, Theodosia Antoniadou, Agni Gavriilidou, Christina Tzitzoglaki, Michail Rallis, David Fedida, Francesc X. Sureda, Cato Mestdagh, Lieve Naesens, Salvatore Chiantia, F. Brent Johnson, Antonios Kolocouris |
| Summary: | To better manage seasonal and pandemic influenza infections, new drugs are needed with enhanced activity against amantadine- and rimantadine-resistant… |
|---|---|
| Item Description: | Im Titel ist "S31N" hochgestellt Online veröffentlicht: 11. Februar 2025, Artikelversion 17. Februar 2025 Gesehen am 11.11.2025 |
| Physical Description: | Online Resource |
| ISSN: | 1872-9096 |
| DOI: | 10.1016/j.antiviral.2025.106104 |